MYO
Price
$4.37
Change
+$0.10 (+2.34%)
Updated
Apr 17 closing price
Capitalization
93.15M
18 days until earnings call
NEO
Price
$9.55
Change
-$0.01 (-0.10%)
Updated
Apr 17 closing price
Capitalization
2.01B
10 days until earnings call
Ad is loading...

MYO vs NEO

Header iconMYO vs NEO Comparison
Open Charts MYO vs NEOBanner chart's image
Myomo
Price$4.37
Change+$0.10 (+2.34%)
Volume$279.53K
Capitalization93.15M
NeoGenomics
Price$9.55
Change-$0.01 (-0.10%)
Volume$1.36M
Capitalization2.01B
MYO vs NEO Comparison Chart
Loading...
MYO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MYO vs. NEO commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MYO is a Hold and NEO is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 19, 2025
Stock price -- (MYO: $4.37 vs. NEO: $9.55)
Brand notoriety: MYO and NEO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: MYO: 62% vs. NEO: 83%
Market capitalization -- MYO: $93.15M vs. NEO: $2.01B
MYO [@Medical Specialties] is valued at $93.15M. NEO’s [@Medical Specialties] market capitalization is $2.01B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MYO’s FA Score shows that 0 FA rating(s) are green whileNEO’s FA Score has 0 green FA rating(s).

  • MYO’s FA Score: 0 green, 5 red.
  • NEO’s FA Score: 0 green, 5 red.
According to our system of comparison, MYO is a better buy in the long-term than NEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MYO’s TA Score shows that 3 TA indicator(s) are bullish while NEO’s TA Score has 5 bullish TA indicator(s).

  • MYO’s TA Score: 3 bullish, 4 bearish.
  • NEO’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, NEO is a better buy in the short-term than MYO.

Price Growth

MYO (@Medical Specialties) experienced а +1.86% price change this week, while NEO (@Medical Specialties) price change was +7.30% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.65%. For the same industry, the average monthly price growth was -9.67%, and the average quarterly price growth was -5.07%.

Reported Earning Dates

MYO is expected to report earnings on Aug 12, 2025.

NEO is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Medical Specialties (+1.65% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEO($2.01B) has a higher market cap than MYO($93.2M). MYO YTD gains are higher at: -32.143 vs. NEO (-42.051). MYO has higher annual earnings (EBITDA): -7.71M vs. NEO (-17.61M). NEO has more cash in the bank: 415M vs. MYO (8.87M). MYO has less debt than NEO: MYO (601K) vs NEO (612M). NEO has higher revenues than MYO: NEO (592M) vs MYO (19.2M).
MYONEOMYO / NEO
Capitalization93.2M2.01B5%
EBITDA-7.71M-17.61M44%
Gain YTD-32.143-42.05176%
P/E RatioN/A49.50-
Revenue19.2M592M3%
Total Cash8.87M415M2%
Total Debt601K612M0%
FUNDAMENTALS RATINGS
MYO vs NEO: Fundamental Ratings
MYO
NEO
OUTLOOK RATING
1..100
2235
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
73
Overvalued
PROFIT vs RISK RATING
1..100
92100
SMR RATING
1..100
9692
PRICE GROWTH RATING
1..100
5780
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MYO's Valuation (46) in the Medical Distributors industry is in the same range as NEO (73) in the Medical Or Nursing Services industry. This means that MYO’s stock grew similarly to NEO’s over the last 12 months.

MYO's Profit vs Risk Rating (92) in the Medical Distributors industry is in the same range as NEO (100) in the Medical Or Nursing Services industry. This means that MYO’s stock grew similarly to NEO’s over the last 12 months.

NEO's SMR Rating (92) in the Medical Or Nursing Services industry is in the same range as MYO (96) in the Medical Distributors industry. This means that NEO’s stock grew similarly to MYO’s over the last 12 months.

MYO's Price Growth Rating (57) in the Medical Distributors industry is in the same range as NEO (80) in the Medical Or Nursing Services industry. This means that MYO’s stock grew similarly to NEO’s over the last 12 months.

MYO's P/E Growth Rating (100) in the Medical Distributors industry is in the same range as NEO (100) in the Medical Or Nursing Services industry. This means that MYO’s stock grew similarly to NEO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MYONEO
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
75%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
72%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 6 days ago
77%
Declines
ODDS (%)
Bearish Trend 13 days ago
87%
Bearish Trend 19 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
80%
Aroon
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
79%
View a ticker or compare two or three
Ad is loading...
MYO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
SPY526.410.75
+0.14%
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla
BTC.X84450.805000-444.945300
-0.52%
Bitcoin cryptocurrency

MYO and

Correlation & Price change

A.I.dvisor tells us that MYO and NEO have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MYO and NEO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYO
1D Price
Change %
MYO100%
+2.34%
NEO - MYO
32%
Poorly correlated
-0.10%
CLPT - MYO
31%
Poorly correlated
+6.25%
MXCT - MYO
31%
Poorly correlated
+2.35%
BLFS - MYO
30%
Poorly correlated
-1.57%
OFIX - MYO
28%
Poorly correlated
+0.54%
More

NEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEO has been loosely correlated with FLGT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if NEO jumps, then FLGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEO
1D Price
Change %
NEO100%
-0.10%
FLGT - NEO
45%
Loosely correlated
-2.51%
RGEN - NEO
45%
Loosely correlated
-1.59%
VCYT - NEO
43%
Loosely correlated
-1.24%
BLFS - NEO
43%
Loosely correlated
-1.57%
CSTL - NEO
42%
Loosely correlated
+1.18%
More